Budget Range
Min
€1,500
Average
€63,181
Max
€298,979
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (28)
P
Protein-ligand data generation at scale to support computational hit finding and optimization
Health101252959
€298,979
P
Providing cutting edge cancer research services across Europe
HORIZON.1.3101058620
€148,664
P
Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
Health101172872
€124,388
P
EUropean Cancer Information Portal
Health101214125
€119,992
P
Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy
Health101057695
€99,967
P
COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Health101103746
€99,841
P
Data-driven cancer genome interpretation for personalised cancer treatment
Health101057509
€95,843
P
Open Consortium for Decentralized Medical Artificial Intelligence
Health101057091
€86,918
P
A European-wide foundation to accelerate Data-driven Cancer Research
Research Infrastructures101058427
€78,145
P
AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
Health101080756
€69,378
P
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
Health101214326
€62,397
P
A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL
Health101104657
€59,998
C
Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors
Health101104684
€59,988
P
PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials
Health101104269
€59,687
P
First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma
Health101104801
€55,777
P
CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE
Health101095483
€46,422
P
Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS
Nuclear Research (Euratom)101166699
€34,932
P
MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT
Health101137206
€30,000
P
A Coordination and Support Action to prepare UNCAN.eu platform
Health101069496
€29,896
C
Maximizing the use of a first clinically viable MYC inhibitor
HORIZON.1.1101142260
€24,999
C
VHIO International postDoctoral programme for translAtional research
MSCA (Marie Skłodowska-Curie)101179122
€17,194
C
Unraveling the Functional Complexity of Cancer Genomes through Chromosome Engineering
HORIZON.1.1101041659
€16,044
P
IRB Barcelona International PhD Programme: Driving talent towards professional excellence and high impact biomedicine.
MSCA (Marie Skłodowska-Curie)101217394
€15,840
P
IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions
MSCA (Marie Skłodowska-Curie)101217395
€15,840
P
IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine
MSCA (Marie Skłodowska-Curie)101126676
€13,440
P
Nanoengineered particles for enhanced cancer radiotherapy
HORIZON.1.1101189443
€1,500
C
Bringing MYC inhibition to the brain by ultrasound technology
HORIZON.1.1101247187
€1,500
P
Drug-loaded nanobots for transmucosal delivery to mucinous tumours
ERC (European Research Council)101138723
€1,500